Ki-67 Expression of 50% Is the Optimal Cut-Off to Predict Survival Outcomes in Mantle Cell Lymphoma (MCL): A Pooled Analysis from CALGB 50403 (Alliance) and MCL Real-World Study Cohort
Year: 2023
Type: conference-abstract
Source: Blood
Authors: Narendranath Epperla, Jeffrey M. Switchenko, Susan M. Geyer, Veronika Bachanova, Stefan K. Barta, Alexey Danilov, Natalie S. Grover, Reem Karmali, Brian T. Hill, Nilanjan Ghosh, Timothy S. Fenske, Peter Martin, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Eric D. Hsi, Kami J. Maddocks, Kristie A. Blum, Thomas M. Habermann, Matthew J. Maurer, Lawrence David Kaplan, Nancy L. Bartlett, John P. Leonard, Jonathon B. Cohen
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Emory University, Mayo Clinic, University of Minnesota, Abramson Cancer Center, University of Pennsylvania, City Of Hope National Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Cleveland Clinic, Levine Cancer Institute, Medical College of Wisconsin, Weill Cornell Medicine, Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, University of Iowa Hospitals and Clinics, Atrium Health Wake Forest Baptist, Winship Cancer Institute, University of California, San Francisco
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389247167